ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Investigational drugs in phase I and phase II clinical trials for thalassemia
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2017.1335709
◽
2017
◽
Vol 26
(7)
◽
pp. 793-802
◽
Cited By ~ 18
Author(s):
Irene Motta
◽
Natalia Scaramellini
◽
Maria Domenica Cappellini
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Phase Ii Clinical Trials
◽
Investigational Drugs
Download Full-text
Related Documents
Cited By
References
Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2019.1646727
◽
2019
◽
Vol 28
(8)
◽
pp. 733-740
◽
Cited By ~ 2
Author(s):
Alessio Molfino
◽
Maria Ida Amabile
◽
Antonella Giorgi
◽
Massimo Monti
◽
Vito D’Andrea
◽
...
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Cancer Cachexia
◽
Phase Ii Clinical Trials
◽
Investigational Drugs
Download Full-text
Investigational drugs in phase I and phase II clinical trials for hereditary angioedema
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2018.1415325
◽
2017
◽
Vol 27
(1)
◽
pp. 87-103
◽
Cited By ~ 4
Author(s):
Henriette Farkas
◽
Márta Lídia Debreczeni
◽
Kinga Viktória Kőhalmi
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Hereditary Angioedema
◽
Phase Ii Clinical Trials
◽
Investigational Drugs
Download Full-text
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn’s disease
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2018.1506764
◽
2018
◽
Vol 27
(8)
◽
pp. 649-660
◽
Cited By ~ 5
Author(s):
Christopher Ma
◽
Vipul Jairath
◽
Reena Khanna
◽
Brian G. Feagan
Keyword(s):
Clinical Trials
◽
Crohn’S Disease
◽
Crohn's Disease
◽
Phase I
◽
Phase Ii
◽
Phase Ii Clinical Trials
◽
Investigational Drugs
◽
Interleukin 23
Download Full-text
Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2017.1385761
◽
2017
◽
Vol 26
(11)
◽
pp. 1239-1248
◽
Cited By ~ 6
Author(s):
Adamantia Liapikou
◽
Catia Cillóniz
◽
Antoni Torres
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Community Acquired Pneumonia
◽
Phase Ii Clinical Trials
◽
Investigational Drugs
Download Full-text
CTLA4 antagonists in phase I and phase II clinical trials, current status and future perspectives for cancer therapy
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2019.1559297
◽
2018
◽
Vol 28
(2)
◽
pp. 149-159
◽
Cited By ~ 11
Author(s):
Bartosz Szostak
◽
Filip Machaj
◽
Jakub Rosik
◽
Andrzej Pawlik
Keyword(s):
Clinical Trials
◽
Cancer Therapy
◽
Phase I
◽
Phase Ii
◽
Current Status
◽
Future Perspectives
◽
Phase Ii Clinical Trials
Download Full-text
Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2018.1502269
◽
2018
◽
Vol 27
(8)
◽
pp. 677-690
◽
Cited By ~ 3
Author(s):
Leigh C Walker
◽
Andrew J Lawrence
Keyword(s):
Clinical Trials
◽
Alcohol Use
◽
Phase I
◽
Phase Ii
◽
Alcohol Use Disorders
◽
Investigational Drug
◽
Phase Ii Clinical Trials
Download Full-text
Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development
Cancer Medicine
◽
10.1002/cam4.1958
◽
2019
◽
Vol 8
(2)
◽
pp. 585-592
◽
Cited By ~ 2
Author(s):
Daniel Y. Lee
◽
Arthur P. Staddon
◽
Jacob E. Shabason
◽
Ronnie Sebro
Keyword(s):
Clinical Trials
◽
Drug Discovery
◽
Phase I
◽
Phase Ii
◽
Drug Discovery And Development
◽
Phase Ii Clinical Trials
Download Full-text
PHASE I AND PRELIMINARY PHASE II CLINICAL TRIALS OF BESTATIN
Small Molecular Immunomodifiers of Microbial Origin
◽
10.1016/b978-0-08-027993-0.50015-1
◽
1981
◽
pp. 159-172
◽
Cited By ~ 1
Author(s):
Hisashi MAJIMA
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Phase Ii Clinical Trials
◽
Preliminary Phase
Download Full-text
Investigational drugs in phase II clinical trials for acute coronary syndromes
Expert Opinion on Investigational Drugs
◽
10.1080/13543784.2020.1708324
◽
2020
◽
Vol 29
(1)
◽
pp. 33-47
◽
Cited By ~ 3
Author(s):
Amit Rout
◽
Ajaypaul Sukhi
◽
Rahul Chaudhary
◽
Kevin P Bliden
◽
Udaya S Tantry
◽
...
Keyword(s):
Clinical Trials
◽
Phase Ii
◽
Acute Coronary Syndromes
◽
Phase Ii Clinical Trials
◽
Investigational Drugs
◽
Coronary Syndromes
Download Full-text
Abstract 3809: Evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in spontaneous canine cancer: Results of phase I and phase II clinical trials
10.1158/1538-7445.am2014-3809
◽
2014
◽
Cited By ~ 1
Author(s):
Cheryl A. London
◽
Luis Feo Bernabe
◽
Sandra Barnard
◽
William Kisseberth
◽
Antonella Borgatti
◽
...
Keyword(s):
Clinical Trials
◽
Phase I
◽
Phase Ii
◽
Nuclear Export
◽
Selective Inhibitor
◽
The Novel
◽
Phase Ii Clinical Trials
◽
Canine Cancer
◽
Orally Bioavailable
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close